On 24 August 2018, orphan designation (EU/3/18/2062) was granted by the European Commission to IQVIA RDS Ireland Limited, Ireland, for bertilimumab for the treatment of bullous pemphigoid.
So remind me what’s so special about Ireland again? Who’s in Ireland? Why Ireland? I like Ireland.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.